123 related articles for article (PubMed ID: 35398623)
1. Evaluation of plasma LC3B
Chen YQ; Zheng L; Zhou J; Wang P; Wang L; Zhang Y; Man ZS; Chen YH; Gu F; Niu GP
Int Immunopharmacol; 2022 Jul; 108():108760. PubMed ID: 35398623
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-derived LC3B
Chen YQ; Man ZS; Zheng L; Zhang Y; Zhao CW; Ma YT; Zhou J; Wang P; Yu Y; Gu F; Niu GP
Clin Immunol; 2024 Apr; 261():109925. PubMed ID: 38310993
[TBL] [Abstract][Full Text] [Related]
3. IL-6 secretion of CD4
Zhu XL; Wang HJ; Wang XR; Wu D; Ji X; Xu L; Yang Q; Guo JY; Rong Y; Pan N; Cai YL
Clin Transl Oncol; 2022 Nov; 24(11):2222-2230. PubMed ID: 35871126
[TBL] [Abstract][Full Text] [Related]
4. Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes.
Graham R; Gazinska P; Zhang B; Khiabany A; Sinha S; Alaguthurai T; Flores-Borja F; Vicencio J; Beuron F; Roxanis I; Matkowski R; Liam-Or R; Tutt A; Ng T; Al-Jamal KT; Zhou Y; Irshad S
Front Immunol; 2023; 14():1204224. PubMed ID: 37441083
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
[TBL] [Abstract][Full Text] [Related]
6. Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial.
Fu Y; Xu X; Huang D; Cui D; Liu L; Liu J; He Z; Liu J; Zheng S; Luo Y
EBioMedicine; 2017 Oct; 24():56-63. PubMed ID: 28939487
[TBL] [Abstract][Full Text] [Related]
7. Isolation and analysis of tumor‑derived extracellular vesicles from head and neck squamous cell carcinoma plasma by galectin‑based glycan recognition particles.
Benecke L; Chiang DM; Ebnoether E; Pfaffl MW; Muller L
Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36129151
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
Boddu VK; Zamzow P; Kramer MW; Merseburger AS; Gorantla SP; Klinger M; Cramer L; Sauer T; Gemoll T; von Bubnoff N; Gieseler F; Darabi M
Cell Commun Signal; 2024 Feb; 22(1):129. PubMed ID: 38360687
[TBL] [Abstract][Full Text] [Related]
9. Selective Internal Radiotherapy Changes the Immune Profiles of Extracellular Vesicles and Their Immune Origin in Patients with Inoperable Cholangiocarcinoma.
Haag F; Manikkam A; Kraft D; Bär C; Wilke V; Nowak AJ; Bertrand J; Omari J; Pech M; Gylstorff S; Relja B
Cells; 2022 Jul; 11(15):. PubMed ID: 35954154
[TBL] [Abstract][Full Text] [Related]
10. Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
Serratì S; Di Fonte R; Porcelli L; De Summa S; De Risi I; Fucci L; Ruggieri E; Marvulli TM; Strippoli S; Fasano R; Rafaschieri T; Guida G; Guida M; Azzariti A
J Exp Clin Cancer Res; 2023 Sep; 42(1):251. PubMed ID: 37759291
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the prognostic, diagnostic and immunological role of HSP90α in malignant tumors.
Yuan Z; Wang L; Chen C
Front Oncol; 2022; 12():963719. PubMed ID: 36158677
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma.
Juratli MA; Pollmann NS; Oppermann E; Mohr A; Roy D; Schnitzbauer A; Michalik S; Vogl T; Stoecklein NH; Houben P; Katou S; Becker F; Hoelzen JP; Andreou A; Pascher A; Bechstein WO; Struecker B
Sci Rep; 2024 Mar; 14(1):5322. PubMed ID: 38438456
[TBL] [Abstract][Full Text] [Related]
13. Surface Engineering of HEK293 Cell-Derived Extracellular Vesicles for Improved Pharmacokinetic Profile and Targeted Delivery of IL-12 for the Treatment of Hepatocellular Carcinoma.
Zhang J; Song H; Dong Y; Li G; Li J; Cai Q; Yuan S; Wang Y; Song H
Int J Nanomedicine; 2023; 18():209-223. PubMed ID: 36660339
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles.
Deng J; Ke H
Oncoimmunology; 2023; 12(1):2152635. PubMed ID: 36605619
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-375 in extracellular vesicles - novel marker for esophageal cancer diagnosis.
Chen J; Cai Z; Hu J; Zhou L; Zhang P; Xu X
Medicine (Baltimore); 2023 Feb; 102(5):e32826. PubMed ID: 36749234
[TBL] [Abstract][Full Text] [Related]
16. Circulating extracellular vesicle-derived MARCKSL1 is a potential diagnostic non-invasive biomarker in metastatic colorectal cancer patients.
Rong W; Shao S; Pu Y; Ji Q; Zhu H
Sci Rep; 2023 Jun; 13(1):9957. PubMed ID: 37340044
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Detection of PD-L1 Protein and mRNA in Tumor Cells and Extracellular Vesicles through a Real-Time qPCR Assay.
Peng W; Sun D; Lu W; Yin S; Ye B; Wang X; Ren Y; Hong Z; Zhu W; Yu P; Xi JJ; Yao B
Anal Chem; 2023 Jul; 95(28):10625-10633. PubMed ID: 37424077
[TBL] [Abstract][Full Text] [Related]
18. Engineered CD8
Cho H; Jung I; Ju H; Baek MC; Yea K
Cytokine; 2023 Sep; 169():156249. PubMed ID: 37290276
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity.
Aharon A; Dangot A; Kinaani F; Zavaro M; Bannon L; Bar-Lev T; Keren-Politansky A; Avivi I; Jacob G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982991
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy.
Černe K; Kelhar N; Resnik N; Herzog M; Vodnik L; Veranič P; Kobal B
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
